Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.